Hyperthermic isolated limb perfusion increases circulating levels of inflammatory cytokines

Hyperthermic isolated limb perfusion is an established method of treatment for regionally advanced melanoma. Recent studies suggest that exogenously administered cytokines potentiate tumor response in patients with in-transit melanoma. We hypothesized that isolated limb perfusion induces an immunoge...

Full description

Saved in:
Bibliographic Details
Published inCancer Immunology, Immunotherapy Vol. 40; no. 4; pp. 272 - 275
Main Authors QUINN, T. D, POLK, J. C, EDWARDS, M. J
Format Journal Article
LanguageEnglish
Published Berlin Springer 01.07.1995
Springer-Verlag
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Hyperthermic isolated limb perfusion is an established method of treatment for regionally advanced melanoma. Recent studies suggest that exogenously administered cytokines potentiate tumor response in patients with in-transit melanoma. We hypothesized that isolated limb perfusion induces an immunogenic response characterized by increased circulating levels of cytokines in the pump circuit, potentially contributing to the antitumor effect. We obtained blood samples from the perfusion circuit and systemic circulation at various intervals from patients undergoing isolated chemotherapeutic perfusion for melanoma. Samples were analyzed for serum cytokine profiles by enzyme-linked immunosorbent assay. When compared with baseline values, significant increases in serum levels of interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor (TNF) occurred within the perfusion circuit during isolated limb perfusion (P < 0.05). In addition, there was a corresponding increase in IL-8 within the systemic circulation at the 60-min interval (P < 0.05), suggesting some degree of leakage from the isolated circuit due to the extremely high levels of IL-8 in the perfusion circuit. A transient but insignificant decrease in circulating levels of neutrophils was also observed during the perfusion process, which may be attributed to margination. Increased levels of cytokines IL-6, IL-8, and TNF occurred within the isolated circuit during hyperthermic limb perfusion and may contribute to tumor response seen in patients treated with isolated limb perfusion.
AbstractList Hyperthermic isolated limb perfusion is an established method of treatment for regionally advanced melanoma. Recent studies suggest that exogenously administered cytokines potentiate tumor response in patients with in-transit melanoma. We hypothesized that isolated limb perfusion induces an immunogenic response characterized by increased circulating levels of cytokines in the pump circuit, potentially contributing to the antitumor effect. We obtained blood samples from the perfusion circuit and systemic circulation at various intervals from patients undergoing isolated chemotherapeutic perfusion for melanoma. Samples were analyzed for serum cytokine profiles by enzyme-linked immunosorbent assay. When compared with baseline values, significant increases in serum levels of interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor (TNF) occurred within the perfusion circuit during isolated limb perfusion (P < 0.05). In addition, there was a corresponding increase in IL-8 within the systemic circulation at the 60-min interval (P < 0.05), suggesting some degree of leakage from the isolated circuit due to the extremely high levels of IL-8 in the perfusion circuit. A transient but insignificant decrease in circulating levels of neutrophils was also observed during the perfusion process, which may be attributed to margination. Increased levels of cytokines IL-6, IL-8, and TNF occurred within the isolated circuit during hyperthermic limb perfusion and may contribute to tumor response seen in patients treated with isolated limb perfusion.
Hyperthermic isolated limb perfusion is an established method of treatment for regionally advanced melanoma. Recent studies suggest that exogenously administered cytokines potentiate tumor response in patients with in-transit melanoma. We hypothesized that isolated limb perfusion induces an immunogenic response characterized by increased circulating levels of cytokines in the pump circuit, potentially contributing to the antitumor effect. We obtained blood samples from the perfusion circuit and systemic circulation at various intervals from patients undergoing isolated chemotherapeutic perfusion for melanoma. Samples were analyzed for serum cytokine profiles by enzyme-linked immunosorbent assay. When compared with baseline values, significant increases in serum levels of interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor (TNF) occurred within the perfusion circuit during isolated limb perfusion ( P <0.05). In addition, there was a corresponding increase in IL-8 within the systemic circulation at the 60-min interval ( P <0.05), suggesting some degree of leakage from the isolated circuit due to the extremely high levels of IL-8 in the perfusion circuit. A transient but insignificant decrease in circulating levels of neutrophils was also observed during the perfusion process, which may be attributed to margination. Increased levels of cytokines IL-6, IL-8, and TNF occurred within the isolated circuit during hyperthermic limb perfusion and may contribute to tumor response seen in patients treated with isolated limb perfusion.
Author QUINN, T. D
EDWARDS, M. J
POLK, J. C
Author_xml – sequence: 1
  givenname: T. D
  surname: QUINN
  fullname: QUINN, T. D
  organization: Univ. Louisville, dep. surgery, div. surgical oncology, Louisville KY 40292, United States
– sequence: 2
  givenname: J. C
  surname: POLK
  fullname: POLK, J. C
  organization: Univ. Louisville, dep. surgery, div. surgical oncology, Louisville KY 40292, United States
– sequence: 3
  givenname: M. J
  surname: EDWARDS
  fullname: EDWARDS, M. J
  organization: Univ. Louisville, dep. surgery, div. surgical oncology, Louisville KY 40292, United States
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3517879$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/7750126$$D View this record in MEDLINE/PubMed
BookMark eNpVkEFLxDAQRoOs6Lp68S704EmoTtK0aU-ii7qC4MWbhzLNTjTaJkvSXei_t-Ky6mkG3ptv4DtiE-cdMXbK4ZIDqKvbe-A5ryoQe2zKZSZSKHM-YVPIJKQKQB6yoxg_xkVAVR2wA6Vy4KKYstfFsKLQv1PorE5s9C32tExa2zXJCMw6Wu8S63QgjBQTbYNej451b0lLG2pj4s3ITYtdh70PQ6KH3n9aR_GY7RtsI51s54y93N-9zBfp0_PD4_zmKdVZofqUeJGrRmVQSqywlEZJI1GLQjcGSwFYASI2kgRIBZKWy4ag0UKWXBlqshm7_oldrZuOlppcH7CtV8F2GIbao63_E2ff6ze_qTmHTBUVjAkXPwk6-BgDmd0xh_q74fq34VE--_tup24rHfn5lmPU2JqATtu407Kcq1JV2RdscohE
CODEN CIIMDN
CitedBy_id crossref_primary_10_1002__SICI_1097_0142_19970315_79_6_1129__AID_CNCR11_3_0_CO_2_1
crossref_primary_10_1097_00002371_200107000_00011
crossref_primary_10_1200_JCO_2002_01_003
crossref_primary_10_1002__SICI_1096_9098_199903_70_3_185__AID_JSO8_3_0_CO_2
crossref_primary_10_1016_S0003_4975_97_00506_7
crossref_primary_10_1053_ejso_1999_0687
Cites_doi 10.1200/JCO.1991.9.12.2091
10.1016/S0021-9258(18)37790-1
10.1016/0003-4975(92)91446-G
10.1016/0140-6736(93)90416-E
10.1016/0002-9610(65)90076-0
10.4049/jimmunol.142.3.808
10.1200/JCO.1992.10.1.52
10.1093/ajcp/66.5.840
10.1097/00000658-195810000-00009
10.1042/bj2650621
10.1016/0014-5793(89)80476-4
10.1016/S0041-008X(71)80026-1
10.1172/JCI112721
10.1001/archsurg.1990.01410150039008
10.1146/annurev.bi.57.070188.002445
10.1016/0006-2952(72)90384-X
10.1002/1097-0142(19860515)57:10<1923::AID-CNCR2820571006>3.0.CO;2-E
ContentType Journal Article
Copyright 1995 INIST-CNRS
Springer-Verlag 1995
Copyright_xml – notice: 1995 INIST-CNRS
– notice: Springer-Verlag 1995
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
5PM
DOI 10.1007/BF01519902
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1432-0851
EndPage 275
ExternalDocumentID 10_1007_BF01519902
7750126
3517879
Genre Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GroupedDBID ---
-53
-56
-5G
-BR
-EM
-Y2
-~C
.55
.86
.VR
06C
06D
0R~
0VY
199
1N0
1SB
2.D
203
28-
29B
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5RE
5VS
67Z
6J9
6NX
78A
7X7
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AABYN
AAFGU
AAHNG
AAIAL
AAJKR
AAKSU
AANXM
AANZL
AAPBV
AARHV
AARTL
AATNV
AATVU
AAUGY
AAUYE
AAWCG
AAYFA
AAYIU
AAYQN
AAYTO
ABBBX
ABBXA
ABDZT
ABECU
ABFGW
ABFTV
ABHLI
ABHQN
ABIPD
ABJOX
ABKAS
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABPTK
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABUWZ
ABWNU
ABXPI
ACBMV
ACBRV
ACBXY
ACBYP
ACGFS
ACHSB
ACHVE
ACHXU
ACIGE
ACIHN
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPRK
ACREN
ACTTH
ACUDM
ACVWB
ACWMK
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADMDM
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZKW
AEAQA
AEBTG
AEEQQ
AEFIE
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFAFS
AFEXP
AFJLC
AFKRA
AFLOW
AFNRJ
AFQWF
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGGBP
AGGDS
AGJBK
AGKHE
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AJZVZ
AKMHD
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBNVY
BBWZM
BDATZ
BENPR
BGNMA
BHPHI
BPHCQ
BVXVI
CAG
CCPQU
COF
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
H13
HCIFZ
HF~
HG5
HG6
HMJXF
HQYDN
HRMNR
HZ~
I09
IH2
IHE
IJ-
IKXTQ
IMOTQ
IQODW
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LK8
LLZTM
M1P
M4Y
M7P
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
ROL
RPX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SBL
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UDS
UG4
UKHRP
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
X7M
YLTOR
Z45
Z7U
Z7V
Z7X
Z82
Z83
Z84
Z87
Z8O
Z8P
Z8V
Z8W
Z8Y
Z91
ZGI
ZMTXR
ZOVNA
~EX
~KM
AAEOY
AAKKN
AAYZH
ABAKF
ABEEZ
ABJNI
ACACY
ACULB
ACZOJ
AEFQL
AFBBN
AFGXO
AGQEE
AGRTI
AJOOF
ALIPV
C24
C6C
CGR
CUY
CVF
ECM
EIF
HMCUK
HVGLF
NPM
RPM
AAYXX
CITATION
5PM
ID FETCH-LOGICAL-c367t-e1657b73084a9a84f74f4ac26cbfa820a90aaab4e204704eddbe0bc24817feb3
IEDL.DBID RPM
ISSN 0340-7004
IngestDate Tue Sep 17 21:28:18 EDT 2024
Thu Sep 12 18:50:15 EDT 2024
Sat Nov 02 12:05:47 EDT 2024
Sun Oct 29 17:07:31 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Antineoplastic agent
Regional treatment
Cytokine
Melanoma
Malignant tumor
Interleukin 6
Local administration
Chemotherapy
Perfusion
Limb
Advanced stage
Combined treatment
Tumor necrosis factor α
Induced hyperthermia
Interleukin 8
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c367t-e1657b73084a9a84f74f4ac26cbfa820a90aaab4e204704eddbe0bc24817feb3
PMID 7750126
PageCount 4
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11037690
crossref_primary_10_1007_BF01519902
pubmed_primary_7750126
pascalfrancis_primary_3517879
PublicationCentury 1900
PublicationDate 1995-07-00
PublicationDateYYYYMMDD 1995-07-01
PublicationDate_xml – month: 07
  year: 1995
  text: 1995-07-00
PublicationDecade 1990
PublicationPlace Berlin
PublicationPlace_xml – name: Berlin
– name: Germany
– name: Berlin/Heidelberg
PublicationTitle Cancer Immunology, Immunotherapy
PublicationTitleAlternate Cancer Immunol Immunother
PublicationYear 1995
Publisher Springer
Springer-Verlag
Publisher_xml – name: Springer
– name: Springer-Verlag
References J Le (BF01519902_CR14) 1989; 61
L Hafström (BF01519902_CR11) 1991; 9
H Martijn (BF01519902_CR18) 1986; 57
MJ Edwards (BF01519902_CR8) 1990; 125
G Morrone (BF01519902_CR21) 1988; 263
FR Balkwill (BF01519902_CR1) 1986; 46
CH Wortel (BF01519902_CR28) 1993; 114
P Calabresi (BF01519902_CR4) 1990
BF01519902_CR20
JV Castell (BF01519902_CR5) 1989; 242
PP Saunders (BF01519902_CR23) 1974; 34
AT Lefor (BF01519902_CR15) 1994; 116
JS Stehlin (BF01519902_CR25) 1965; 110
PC Heinrich (BF01519902_CR12) 1990; 265
SC Donnelly (BF01519902_CR7) 1993; 341
S Marinkovic (BF01519902_CR17) 1989; 142
J Butler (BF01519902_CR3) 1992; 53
M Vaglini (BF01519902_CR27) 1987; 13
B Beutler (BF01519902_CR2) 1988; 57
AH Gerulath (BF01519902_CR10) 1972; 21
O Creech Jr (BF01519902_CR6) 1958; 148
C Fischer (BF01519902_CR9) 1976; 66
ET Krementz (BF01519902_CR13) 1985
D Lienard (BF01519902_CR16) 1992; 10
JS Stehlin (BF01519902_CR26) 1975; 140
NS Mizuno (BF01519902_CR19) 1972; 56
DH Perlmutter (BF01519902_CR22) 1986; 78
JL Skibba (BF01519902_CR24) 1971; 18
References_xml – volume: 9
  start-page: 2091
  year: 1991
  ident: BF01519902_CR11
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.1991.9.12.2091
  contributor:
    fullname: L Hafström
– volume: 263
  start-page: 12554
  year: 1988
  ident: BF01519902_CR21
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)37790-1
  contributor:
    fullname: G Morrone
– volume: 140
  start-page: 339
  year: 1975
  ident: BF01519902_CR26
  publication-title: Surg Gynecol Obstet
  contributor:
    fullname: JS Stehlin
– start-page: 1209
  volume-title: The pharmacological basis of therapeutics
  year: 1990
  ident: BF01519902_CR4
  contributor:
    fullname: P Calabresi
– volume: 53
  start-page: 833
  year: 1992
  ident: BF01519902_CR3
  publication-title: Ann Thorac Surg
  doi: 10.1016/0003-4975(92)91446-G
  contributor:
    fullname: J Butler
– volume: 341
  start-page: 643
  year: 1993
  ident: BF01519902_CR7
  publication-title: Lancet
  doi: 10.1016/0140-6736(93)90416-E
  contributor:
    fullname: SC Donnelly
– volume: 56
  start-page: 465
  year: 1972
  ident: BF01519902_CR19
  publication-title: Cancer Chemother Rep
  contributor:
    fullname: NS Mizuno
– volume: 110
  start-page: 366
  year: 1965
  ident: BF01519902_CR25
  publication-title: Am J Surg
  doi: 10.1016/0002-9610(65)90076-0
  contributor:
    fullname: JS Stehlin
– volume: 142
  start-page: 808
  year: 1989
  ident: BF01519902_CR17
  publication-title: J Immunol
  doi: 10.4049/jimmunol.142.3.808
  contributor:
    fullname: S Marinkovic
– volume: 10
  start-page: 52
  year: 1992
  ident: BF01519902_CR16
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.1992.10.1.52
  contributor:
    fullname: D Lienard
– volume: 66
  start-page: 840
  year: 1976
  ident: BF01519902_CR9
  publication-title: Am J Clin Pathol
  doi: 10.1093/ajcp/66.5.840
  contributor:
    fullname: C Fischer
– volume: 116
  start-page: 214
  year: 1994
  ident: BF01519902_CR15
  publication-title: Surgery
  contributor:
    fullname: AT Lefor
– volume: 148
  start-page: 616
  year: 1958
  ident: BF01519902_CR6
  publication-title: Ann Surg
  doi: 10.1097/00000658-195810000-00009
  contributor:
    fullname: O Creech Jr
– volume: 265
  start-page: 621
  year: 1990
  ident: BF01519902_CR12
  publication-title: Biochem J
  doi: 10.1042/bj2650621
  contributor:
    fullname: PC Heinrich
– volume: 114
  start-page: 564
  year: 1993
  ident: BF01519902_CR28
  publication-title: Surgery
  contributor:
    fullname: CH Wortel
– start-page: 171
  volume-title: Cutaneous melanoma: clinical management and treatment results worldwide
  year: 1985
  ident: BF01519902_CR13
  contributor:
    fullname: ET Krementz
– volume: 13
  start-page: 127
  year: 1987
  ident: BF01519902_CR27
  publication-title: Eur J Surg Oncol
  contributor:
    fullname: M Vaglini
– volume: 46
  start-page: 3990
  year: 1986
  ident: BF01519902_CR1
  publication-title: Cancer Res
  contributor:
    fullname: FR Balkwill
– volume: 242
  start-page: 237
  year: 1989
  ident: BF01519902_CR5
  publication-title: FEBS Lett
  doi: 10.1016/0014-5793(89)80476-4
  contributor:
    fullname: JV Castell
– volume: 18
  start-page: 707
  year: 1971
  ident: BF01519902_CR24
  publication-title: Toxicol Appl Pharmacol
  doi: 10.1016/S0041-008X(71)80026-1
  contributor:
    fullname: JL Skibba
– volume: 78
  start-page: 1349
  year: 1986
  ident: BF01519902_CR22
  publication-title: J Clin Invest
  doi: 10.1172/JCI112721
  contributor:
    fullname: DH Perlmutter
– volume: 125
  start-page: 317
  year: 1990
  ident: BF01519902_CR8
  publication-title: Arch Surg
  doi: 10.1001/archsurg.1990.01410150039008
  contributor:
    fullname: MJ Edwards
– ident: BF01519902_CR20
– volume: 57
  start-page: 505
  year: 1988
  ident: BF01519902_CR2
  publication-title: Annu Rev Biochem
  doi: 10.1146/annurev.bi.57.070188.002445
  contributor:
    fullname: B Beutler
– volume: 61
  start-page: 588
  year: 1989
  ident: BF01519902_CR14
  publication-title: Lab Invest
  contributor:
    fullname: J Le
– volume: 34
  start-page: 2464
  year: 1974
  ident: BF01519902_CR23
  publication-title: Cancer Res
  contributor:
    fullname: PP Saunders
– volume: 21
  start-page: 2335
  year: 1972
  ident: BF01519902_CR10
  publication-title: Biochem Pharmacol
  doi: 10.1016/0006-2952(72)90384-X
  contributor:
    fullname: AH Gerulath
– volume: 57
  start-page: 1923
  year: 1986
  ident: BF01519902_CR18
  publication-title: Cancer
  doi: 10.1002/1097-0142(19860515)57:10<1923::AID-CNCR2820571006>3.0.CO;2-E
  contributor:
    fullname: H Martijn
SSID ssj0042099
ssj0001254
Score 1.5393668
Snippet Hyperthermic isolated limb perfusion is an established method of treatment for regionally advanced melanoma. Recent studies suggest that exogenously...
SourceID pubmedcentral
crossref
pubmed
pascalfrancis
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 272
SubjectTerms Antineoplastic agents
Antineoplastic Combined Chemotherapy Protocols - administration & dosage
Biological and medical sciences
Chemotherapy, Cancer, Regional Perfusion
Combined Modality Therapy
Combined treatments (chemotherapy of immunotherapy associated with an other treatment)
Cytokines - blood
Dactinomycin - administration & dosage
Drug Administration Schedule
Extremities
Humans
Hyperthermia, Induced
Inflammation - blood
Inflammation - etiology
Infusion Pumps
Mechlorethamine - administration & dosage
Medical sciences
Melanoma - blood
Melanoma - therapy
Pharmacology. Drug treatments
Short Communication
Title Hyperthermic isolated limb perfusion increases circulating levels of inflammatory cytokines
URI https://www.ncbi.nlm.nih.gov/pubmed/7750126
https://pubmed.ncbi.nlm.nih.gov/PMC11037690
Volume 40
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEB7aglIQ8VWsWlnQa9o8NpvkKMVShIqHCgUPZXezq8EmLU178N87mzS1uXpMJoEw-XZnZuebGYBHhEnAfSUtEQtmUYdrXHOeb-lQonVSzPaKcW-TVzZ-py8zf9YAVtXCFKR9KZJ-tkj7WfJVcCtXqRxUPLHB22TomOI2DOsGTWgiQqsYvV2drBgLWV5QUxlaJBIMcQ6v6x1K0dzhbuy24ShAy-mYDgsH1ulkxXNUlC4nXByYqDp98sAejc7gdOdIkqfyg8-hobILOJ7sUuWX8DHGCHNt3Ls0kSRBiKFXGZNFkgqCAr01x2QkyYzXmKucyGQti1Fe2SdZGCZRTpYa5RohkxapeCJ_NstvQ5O_gunoeTocW7tJCpb0WLCxlMP8QKCqQsojHlIdUE25dJkUmqMPwCObcy6ocm0a2FTFsVC2kC4NnUBjuN2BVrbM1DUQyRnXPvMkFRE1Sc4Qb3iRjKgb43q2u_BQKXC-KvtlzKvOyH8K70Kvptv9o57v4A4SdaFTqngv2P2fLoQ13e_lpkt2XYLgKbplV2C5-f-rt9AuK9kNS_cOWpv1VvXQF9mI-wJ6v21Q3uY
link.rule.ids 230,315,730,783,787,888,27936,27937,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDLbGEDAJIZ5iwCASXMv6SNP2iBDTgA1xGNIkDlOSJlCxdtM2Dvx7nHYd65Vj6laqHDu24882wA2KScB9JS0RC2ZRh2vUOc-3dCjROilme_m4t_4L677Rp6E_rAEra2Fy0L4UyW02Tm-z5DPHVk5T2S5xYu3X_r1jitswrGtvwCYqrE3LKL1R3q0YG1ksqKkNzVMJBjqH62qPUjR4eB67DdgK0HY6psfCmn3anfI5skoXMy7WjFQVQLlmkTr7sLd0Jcld8csHUFPZIWz3l8nyI3jvYow5Mw5emkiSoJChXxmTcZIKggT9bS7KSJIZv3Gu5kQmM5kP88o-yNhgieZkopGuUWjSPBlP5M9i8mWA8scw6DwM7rvWcpaCJT0WLCzlMD8QqM4h5REPqQ6oply6TArN0Qvgkc05F1S5Ng1squJYKFtIl4ZOoDHgPoF6NsnUKRDJGdc-8yQVETVpzhAfeJGMqBujRttNuC4ZOJoWHTNGZW_kP4Y3oVXh7epVz3fwDImacFKweEVY7k8TwgrvV3TTJ7tKQfHJ-2WX4nL2_0-vYKc76PdGvceX53NoFHXtBrN7AfXF7Fu10DNZiMtcDH8BUqbiPA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDLZ4CDQJIZ5iwCASXMv6SNP2iAbTeAxxAAmJw5SkCVSs3bSOA_8ep4-xXjm2bqXKtfPZ8Rcb4BLNJOC-kpaIBbOowzX6nOdbOpSITorZXjHubfjEBq_0_s1_q1iVeUWrzKRIrrJxepUlnwW3cprKbs0T6z4Pe4453IZpXXca6-4qrKPT2qzO1Fv1_orByfKCmvOhRTnB0OfwutmnFEEP12S3BRsB4qdj-iwsYdTWlOeoLl3OuVgCqiaJcgmV-juwXYWT5Lr87F1YUdkebA6rgvk-vA8wz5yZIC9NJEnQ0DC2jMk4SQVBgf42m2UkyUzsmKucyGQmi4Fe2QcZGz5RTiYa5RoNJy0K8kT-zCdfhix_AC_925fewKrmKVjSY8HcUg7zA4EuHVIe8ZDqgGrKpcuk0BwjAR7ZnHNBlWvTwKYqjoWyhXRp6AQak-5DWMsmmToCIjnj2meepCKiptQZ4g0vkhF1Y_Rquw0XtQJH07Jrxqjuj_yn8DZ0GrpdPOr5Dq4jURsOSxUvBNX_aUPY0P1CbnplNyVoQkXP7Npkjv__6jlsPt_0R493Tw8n0CqPthva7imszWffqoPByVycFVb4C5y0408
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hyperthermic+isolated+limb+perfusion+increases+circulating+levels+of+inflammatory+cytokines&rft.jtitle=Cancer+Immunology%2C+Immunotherapy&rft.au=Quinn%2C+Terre+D.&rft.au=Polk%2C+Hiram+C.&rft.au=Edwards%2C+Michael+J.&rft.date=1995-07-01&rft.issn=0340-7004&rft.eissn=1432-0851&rft.volume=40&rft.issue=4&rft.spage=272&rft.epage=275&rft_id=info:doi/10.1007%2FBF01519902&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_BF01519902
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0340-7004&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0340-7004&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0340-7004&client=summon